Yifang Wei

747 total citations
13 papers, 601 citations indexed

About

Yifang Wei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yifang Wei has authored 13 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Yifang Wei's work include Extracellular vesicles in disease (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Yifang Wei is often cited by papers focused on Extracellular vesicles in disease (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Yifang Wei collaborates with scholars based in China. Yifang Wei's co-authors include Suning Chen, Shentong Yu, Xiaofeng Lai, Yuan Zhang, Libo Yao, Jiän Zhang, Xingmei Zhu, Yongzheng Ma, Huichen Li and Wenchao Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Ethnopharmacology.

In The Last Decade

Yifang Wei

12 papers receiving 594 citations

Peers

Yifang Wei

MB

CR

ONCOL

MC

BE

Huazhang Wu China

Guang‐Bin Sun China

Mayra Rachele Zarone Italy

Sichong Han China

Sarit Tabak Israel

Chengmeng Jin China

Anchal Sharma India

Fang Sui China

Li Tan China

Qiang Peng China

Huazhang Wu China

Yifang Wei

510 ×1.1

MB

398 ×1.2

CR

79 ×1.2

ONCOL

22 ×0.5

MC

20 ×0.5

BE

Citations per year, relative to Yifang Wei Yifang Wei (= 1×) peers Huazhang Wu

Countries citing papers authored by Yifang Wei

Since Specialization

Citations

This map shows the geographic impact of Yifang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifang Wei more than expected).

Fields of papers citing papers by Yifang Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifang Wei. The network helps show where Yifang Wei may publish in the future.

Co-authorship network of co-authors of Yifang Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yifang Wei. A scholar is included among the top collaborators of Yifang Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifang Wei. Yifang Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Wei, Yifang, et al.. (2025). Trajectories of Cognitive Change and Their Association with All-Cause Mortality Among Chinese Older Adults: Results from the Chinese Longitudinal Healthy Longevity Survey. Behavioral Sciences. 15(3). 365–365.

2.

Li, Xingguo, Mengyuan Geng, Yifang Wei, et al.. (2024). Research on the effects of intestinal FXR agonists and antibiotics on the regulation of red kidney bean polysaccharides in the liver metabolism in mice with type 2 diabetes. SHILAP Revista de lepidopterología. 5(3). 5 indexed citations

3.

Zhang, Yuan, Yue Zhang, Yang Sun, et al.. (2022). Bone marrow mesenchymal stem cells-derived exosomal microRNA-16-5p restrains epithelial-mesenchymal transition in breast cancer cells via EPHA1/NF-κB signaling axis. Genomics. 114(3). 110341–110341. 16 indexed citations

4.

Zhang, Yuan, et al.. (2022). Necroptosis-related lncRNA signatures determine prognosis in breast cancer patients. Scientific Reports. 12(1). 11268–11268. 11 indexed citations

5.

Zhang, Wanwan, Yifang Wei, Xiaoxiao Cao, et al.. (2020). Enzymatic preparation of Crassostrea oyster peptides and their promoting effect on male hormone production. Journal of Ethnopharmacology. 264. 113382–113382. 27 indexed citations

6.

Wei, Yifang, et al.. (2020). MicroRNA-135a Regulates VEGFC Expression and Promotes Luteinized Granulosa Cell Apoptosis in Polycystic Ovary Syndrome. Reproductive Sciences. 27(7). 1436–1442. 16 indexed citations

7.

Wei, Yifang, Shentong Yu, Yongping Zhang, et al.. (2017). NDRG2 promotes adriamycin sensitivity through a Bad/p53 complex at the mitochondria in breast cancer. Oncotarget. 8(17). 29038–29047. 12 indexed citations

8.

Yu, Shentong, Yifang Wei, Yuqiao Xu, et al.. (2016). Extracellular vesicles in breast cancer drug resistance and their clinical application. Tumor Biology. 37(3). 2849–2861. 19 indexed citations

9.

Lai, Xiaofeng, Yifang Wei, Hu Zhao, et al.. (2015). The effect of Fe₂O₃ and ZnO nanoparticles on cytotoxicity and glucose metabolism in lung epithelial cells. Journal of Applied Toxicology. 35(6). 651–664. 60 indexed citations

10.

Zhang, Yuan, Yu Wang, Yifang Wei, et al.. (2015). MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition. Scientific Reports. 5(1). 40 indexed citations

11.

Wei, Yifang, Xiaofeng Lai, Shentong Yu, et al.. (2014). Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Research and Treatment. 147(2). 423–431. 300 indexed citations

12.

Ma, Ji, Yan Guo, Suning Chen, et al.. (2014). Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma. BMC Cancer. 14(1). 172–172. 54 indexed citations

13.

Zhu, Xingmei, Hongyu Qiao, Suning Chen, et al.. (2013). Autophagy stimulates apoptosis in HER2‐overexpressing breast cancers treated by lapatinib. Journal of Cellular Biochemistry. 114(12). 2643–2653. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact